Eterna Therapeutics Inc.(ERNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ERNA Eterna Therapeutics Inc.

未开盘 02-24 16:00:00 EST

0.3000

+0.0297

+10.99%

盘后0.3249

+0.0249+8.30%

19:58 EST

最高0.3550	最低0.2906	成交量372.55万
今开0.3000	昨收0.2703	日振幅23.83%
总市值812.55万	流通市值649.34万	总股本2,709万
成交额117.66万	换手率17.21%	流通股本2,164万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ERNA","market":"US","secType":"STK","nameCN":"Eterna Therapeutics Inc.","latestPrice":0.3,"timestamp":1771966800000,"preClose":0.2703,"halted":0,"volume":3725512,"hourTrading":{"tag":"盘后","latestPrice":0.3249,"preClose":0.3,"latestTime":"19:58 EST","volume":82770,"amount":25150.957,"timestamp":1771981109148,"change":0.0249,"changeRate":0.083,"amplitude":0.099667},"delay":0,"changeRate":0.10987791342952277,"floatShares":21644600,"shares":27085100,"eps":-3.760293,"marketStatus":"未开盘","change":0.0297,"latestTime":"02-24 16:00:00 EST","open":0.3,"high":0.355,"low":0.2906,"amount":1176595.8939851199,"amplitude":0.238254,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.760293,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":0,"adr":0,"listingDate":465451200000,"exchange":"NASDAQ","adjPreClose":0.2703,"preHourTrading":{"tag":"盘前","latestPrice":0.2991,"preClose":0.2703,"latestTime":"09:26 EST","volume":244535,"amount":70458.309713,"timestamp":1771943205802,"change":0.0288,"changeRate":0.106548,"amplitude":0.132815},"postHourTrading":{"tag":"盘后","latestPrice":0.3249,"preClose":0.3,"latestTime":"19:58 EST","volume":82770,"amount":25150.957,"timestamp":1771981109148,"change":0.0249,"changeRate":0.083,"amplitude":0.099667},"volumeRatio":0.478782},"requestUrl":"/m/hq/s/ERNA/tweets","defaultTab":"tweets","newsList":[{"id":"1156148626","title":"Ernexa Therapeutics参与虚拟投资者\"What This Means\"环节，重点介绍近期与美国FDA成功举行的Pre-IND会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1156148626","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156148626?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:47","pubTimestamp":1770126441,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics近日参与了虚拟投资者活动\"What This Means\"环节，重点分享了公司近期与美国食品药品监督管理局（FDA）成功举行的新药临床试验前（Pre-IND）会议。该环节旨在深入解读此次会议对公司研发管线的战略意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"1182808693","title":"Ernexa Therapeutics宣布FDA新药临床试验前会议成功 持续推动卵巢癌首个人体试验进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1182808693","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182808693?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:15","pubTimestamp":1767705313,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics近日宣布，其与美国食品药品监督管理局（FDA）举行的新药临床试验前（Pre-IND）会议取得圆满成功。此次会议为公司在卵巢癌领域开展首个人体试验扫清了关键监管障碍。\n公司表示，基于FDA的积极反馈，团队正加速推进相关准备工作，朝着启动首次人体临床试验的目标稳步迈进。这一进展标志着Ernexa Therapeutics在卵巢癌创新疗法开发道路上迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"1111619319","title":"Ernexa Therapeutics在美国血液学会年会上发布卵巢癌治疗领先细胞治疗候选药物的新临床前数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1111619319","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111619319?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:31","pubTimestamp":1765200685,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics在美国血液学会年会上发布卵巢癌治疗领先细胞治疗候选药物的新临床前数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"1173119848","title":"Eterna Therapeutics Inc. 发布强劲季度业绩，强调运营执行和向首个人体细胞疗法试验的进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1173119848","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173119848?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:36","pubTimestamp":1762781770,"startTime":"0","endTime":"0","summary":"Eterna Therapeutics Inc. 发布强劲季度业绩，强调运营执行和向首个人体细胞疗法试验的进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERNA"],"gpt_icon":0},{"id":"1125977913","title":"Ernexa Therapeutics展示与Cellipont Bioservices的战略合作，推动首个人体试验向前发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1125977913","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125977913?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:15","pubTimestamp":1762438516,"startTime":"0","endTime":"0","summary":"Ernexa Therapeutics展示与Cellipont Bioservices的战略合作，推动首个人体试验向前发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"1139202386","title":"Cellipont Bioservices与Ernexa Therapeutics建立细胞治疗生产合作伙伴关系，推进Erna-101在卵巢癌临床试验中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1139202386","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139202386?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:33","pubTimestamp":1761741198,"startTime":"0","endTime":"0","summary":"Cellipont Bioservices与Ernexa Therapeutics建立细胞治疗生产合作伙伴关系，推进Erna-101在卵巢癌临床试验中的应用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERNA","BK4139"],"gpt_icon":0},{"id":"2518227115","title":"Eterna Therapeutics Inc.盘中异动 快速下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227115?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:48","pubTimestamp":1741614503,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时48分，Eterna Therapeutics Inc.股票出现异动，股价快速下挫5.15%。截至发稿，该股报0.271美元/股，成交量9913股，换手率0.02%，振幅0.98%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2661.00%、604.15%、92.35%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214823a26a2b3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214823a26a2b3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","BK4139","LENZ"],"gpt_icon":0},{"id":"2517186621","title":"Eterna Therapeutics Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517186621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517186621?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:50","pubTimestamp":1741294233,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时50分，Eterna Therapeutics Inc.股票出现异动，股价快速上涨5.23%。截至发稿，该股报0.300美元/股，成交量5.3505万股，换手率0.10%，振幅8.91%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为5427.26%、5359.77%、280.61%，振幅较大的相关个股有Plus Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Tonix Pharmaceuticals Holding Corp.，振幅分别为306.80%、127.10%、71.44%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045033989ef4b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045033989ef4b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"gpt_icon":0},{"id":"2516670409","title":"Eterna Therapeutics Inc.盘中异动 股价大跌6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670409?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:57","pubTimestamp":1741100240,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时57分，Eterna Therapeutics Inc.股票出现波动，股价急速下挫6.77%。截至发稿，该股报0.260美元/股，成交量8.5642万股，换手率0.17%，振幅3.23%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1148.61%、1120.17%、547.46%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为44.32%、37.67%、34.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225720989bb3d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225720989bb3d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ERNA","LENZ"],"gpt_icon":0},{"id":"2516655902","title":"Eterna Therapeutics Inc.盘中异动 早盘急速下跌6.88%报0.283美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516655902?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:24","pubTimestamp":1741019081,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时24分，Eterna Therapeutics Inc.股票出现波动，股价急速下挫6.88%。截至发稿，该股报0.283美元/股，成交量5.3856万股，换手率0.10%，振幅3.13%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3748.47%、166.95%、140.50%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Radiopharm Theranostics Limited，振幅分别为206.20%、70.53%、53.50%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304002441abe65764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304002441abe65764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","BK4139","LENZ"],"gpt_icon":0},{"id":"2514332025","title":"Eterna Therapeutics Inc.盘中异动 临近收盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332025?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:42","pubTimestamp":1740688957,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时42分，Eterna Therapeutics Inc.股票出现波动，股价急速下挫5.08%。截至发稿，该股报0.280美元/股，成交量10.6788万股，换手率0.21%，振幅5.93%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1942.80%、409.95%、197.12%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280442389895539f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280442389895539f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"gpt_icon":0},{"id":"2514885664","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大涨12.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514885664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514885664?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580341,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分，Eterna Therapeutics Inc.股票出现异动，股价快速拉升12.44%。截至发稿，该股报0.330美元/股，成交量2.5469万股，换手率0.05%，振幅10.19%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2829.37%、119.05%、90.31%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为35.59%、16.86%、14.35%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223221a254f6a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223221a254f6a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","BK4139","LENZ"],"gpt_icon":0},{"id":"2514016384","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大跌6.04%报0.283美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016384?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:30","pubTimestamp":1740497417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时30分，Eterna Therapeutics Inc.股票出现波动，股价快速下挫6.04%。截至发稿，该股报0.283美元/股，成交量5.8695万股，换手率0.11%，振幅2.99%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1070.68%、947.53%、593.23%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、64.05%、61.16%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233018abdc8d61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233018abdc8d61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","LENZ","BK4139"],"gpt_icon":0},{"id":"2514775489","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775489?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:54","pubTimestamp":1740412484,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时54分，Eterna Therapeutics Inc.股票出现异动，股价快速下挫5.34%。截至发稿，该股报0.298美元/股，成交量4.8094万股，换手率0.09%，振幅10.07%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为233.69%、100.01%、28.36%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为151.09%、55.69%、53.34%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235444a2522804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235444a2522804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","LENZ","BK4139"],"gpt_icon":0},{"id":"2512800764","title":"Eterna Therapeutics Inc.盘中异动 急速上涨7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512800764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512800764?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:54","pubTimestamp":1739987667,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时54分，Eterna Therapeutics Inc.股票出现异动，股价急速拉升7.39%。截至发稿，该股报0.325美元/股，成交量19.427万股，换手率0.38%，振幅7.69%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为647.24%、251.00%、218.65%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为250.83%、159.49%、52.00%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220015427988b51e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220015427988b51e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"gpt_icon":0},{"id":"2512166477","title":"Eterna Therapeutics Inc.盘中异动 早盘快速下挫5.05%报0.292美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166477?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889152,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Eterna Therapeutics Inc.股票出现异动，股价急速跳水5.05%。截至发稿，该股报0.292美元/股，成交量1.9698万股，换手率0.04%，振幅1.30%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Glycomimetics, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为278.93%、95.15%、69.45%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Solid Biosciences Inc.，振幅分别为34.04%、22.30%、18.61%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223232a24aacd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223232a24aacd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"gpt_icon":0},{"id":"2511918506","title":"Eterna Therapeutics Inc.股价飙升11.15% 市值涨128.26万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511918506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511918506?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543474,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Eterna Therapeutics Inc.股票出现波动，股价急速拉升11.15%。截至发稿，该股报0.320美元/股，成交量8.6397万股，换手率0.17%，振幅0.00%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Os Therapies Incorporated涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为975.60%、349.19%、314.94%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Os Therapies Incorporated、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、14.07%、10.73%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422311596231b35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422311596231b35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ERNA","BK4139","LENZ"],"gpt_icon":0},{"id":"2511952101","title":"Eterna Therapeutics Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511952101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511952101?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:32","pubTimestamp":1739460759,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时32分，Eterna Therapeutics Inc.股票出现异动，股价急速上涨5.07%。截至发稿，该股报0.275美元/股，成交量10.8772万股，换手率0.21%，振幅3.85%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Edesa Biotech, Inc.、Dominari Holdings Inc.、Enanta Pharmaceuticals, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2327.78%、1136.84%、153.75%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233239abcdbe16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233239abcdbe16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"gpt_icon":0},{"id":"2510338107","title":"Eterna Therapeutics Inc.盘中异动 急速跳水7.12%报0.300美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338107","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510338107?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:00","pubTimestamp":1739286006,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时00分，Eterna Therapeutics Inc.股票出现波动，股价大幅跳水7.12%。截至发稿，该股报0.300美元/股，成交量3.2239万股，换手率0.06%，振幅3.34%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2441.55%、684.26%、307.69%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为45.29%、37.99%、33.04%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211230006a2420127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211230006a2420127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ERNA"],"gpt_icon":0},{"id":"2510665868","title":"Eterna Therapeutics Inc.盘中异动 股价大跌8.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510665868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510665868?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:57","pubTimestamp":1739199450,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时57分，Eterna Therapeutics Inc.股票出现异动，股价急速跳水8.34%。截至发稿，该股报0.308美元/股，成交量2.2879万股，换手率0.04%，振幅7.39%。Eterna Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2246.85%、1420.72%、828.60%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为59.71%、51.99%、39.57%。Eterna Therapeutics Inc.公司简介：Eterna Therapeutics Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225730abc9abbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225730abc9abbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ERNA","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ernexatx.com","stockEarnings":[{"period":"1week","weight":-0.0912},{"period":"1month","weight":-0.75},{"period":"3month","weight":-0.7826},{"period":"6month","weight":-0.7826},{"period":"1year","weight":-0.9336},{"period":"ytd","weight":-0.75}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ernexa Therapeutics Inc于1984年在特拉华州注册成立。Ernexa是一家晚期临床阶段的生物制药公司，专注于治疗癌症患者的基于IL-2细胞因子的疗法。Ernexa致力于开发IRX-2，一种基于细胞因子的新型疗法，用于治疗癌症患者。IRX-2活性成分，即IL-2和其他关键细胞因子，被假定为信号、增强和恢复被肿瘤抑制的免疫功能，从而使免疫系统能够攻击癌细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.558824,"avgChangeRate":0.130666},{"month":2,"riseRate":0.382353,"avgChangeRate":-0.039267},{"month":3,"riseRate":0.575758,"avgChangeRate":0.028679},{"month":4,"riseRate":0.363636,"avgChangeRate":0.353029},{"month":5,"riseRate":0.393939,"avgChangeRate":-0.040845},{"month":6,"riseRate":0.515152,"avgChangeRate":0.017044},{"month":7,"riseRate":0.264706,"avgChangeRate":-0.033365},{"month":8,"riseRate":0.411765,"avgChangeRate":-0.028873},{"month":9,"riseRate":0.323529,"avgChangeRate":-0.027842},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.041231},{"month":11,"riseRate":0.5,"avgChangeRate":0.055021},{"month":12,"riseRate":0.323529,"avgChangeRate":-0.050712}],"exchange":"NASDAQ","name":"Eterna Therapeutics Inc.","nameEN":"Eterna Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eterna Therapeutics Inc.(ERNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Eterna Therapeutics Inc.(ERNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Eterna Therapeutics Inc.,ERNA,Eterna Therapeutics Inc.股票,Eterna Therapeutics Inc.股票老虎,Eterna Therapeutics Inc.股票老虎国际,Eterna Therapeutics Inc.行情,Eterna Therapeutics Inc.股票行情,Eterna Therapeutics Inc.股价,Eterna Therapeutics Inc.股市,Eterna Therapeutics Inc.股票价格,Eterna Therapeutics Inc.股票交易,Eterna Therapeutics Inc.股票购买,Eterna Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eterna Therapeutics Inc.(ERNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Eterna Therapeutics Inc.(ERNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}